Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ambria Dermatology AB
AB
Active
Org 5566178751
Snickaregatan 10, 566 33
Habo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2001 · 24 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ambria Dermatology AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
45
52
39
57
192
Staff expenses
—
—
—
—
—
EBITDA
−230
−47
−258
−475
−271
Depreciation & amort.
−525
−526
−526
−544
−551
EBIT
−755
−573
−784
−1 019
−822
Net financials
—
—
—
—
—
Profit before tax
45
784
−784
822
−822
Tax
−9
−0
−0
−0
−0
Net profit
36
784
−784
822
−822
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
3 286
3 207
2 451
3 228
2 507
Equity
3 231
3 195
2 412
3 195
2 373
Long-term debt
0
0
0
0
0
Short-term debt
55
12
39
33
134
Total debt
55
12
39
33
134
Financial ratios
5-year trend
EBITDA margin
−511,1 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
98,3 %
This company
38,2 %
Market median
This company
Market median
157% above market
2020
2024
Return on equity
1,1 %
This company
18,4 %
Market median
This company
Market median
94% below market
2020
2024
Net profit margin
80,0 %
This company
8,1 %
Market median
This company
Market median
888% above market
2020
2024
Asset turnover
0,01×
This company
1,12×
Market median
This company
Market median
99% below market
2020
2024
Debt / equity
0,02×
This company
0,62×
Market median
This company
Market median
97% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Ambria Dermatology AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
